DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
| You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
| To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Early, Effective Control of Graves’ Disease Improves Survival, Regardless of Treatment
An early and intensive control of hyperthyroidism in Graves’ disease is associated with reduced mortality and cardiovascular risk independent of the method of treatment, according to findings from a linked-record cohort study.
“We have shown that patients with Graves’ disease have an increased risk of mortality and cardiovascular disease, which can be reduced by effective and early control of hyperthyroidism,” Onyebuchi Okosieme, MD, FRCP, a consultant endocrinologist with Cwm Taf University Health Board in Wales and an honorary senior research fellow at Cardiff University, United Kingdom, told Endocrine Today. “Patients successfully treated with radioactive iodine in the first year of diagnosis had reduced long-term risk for mortality and major adverse cardiovascular events compared with those treated with antithyroid drugs alone or with those treated with radioiodine without control of hyperthyroidism.”
myBinderRelated Content
-
Evidence & EducationTreatment Options in the Young Patient With Graves’ DiseaseThe treatment options in the young patie...
-
Community CenterDiagnosis and Management of Graves Disease – David Cooper, MDEdward H. Livingston, MD discusses Grave...
-
News & MeetingsClinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presen...Horizon Therapeutics plc today announced...
-
People & PlacesUniversity of Pittsburgh Medical Center – Multidisciplinary Thyroid CenterUniversity of Pittsburgh Medical Center ...
-
Evidence & EducationThyroid Eye Disease (TED or Graves’ Eye Disease)Graves' eye disease, also known as thyro...
-
People & PlacesMark J. Lucarelli, MD, FACSMark J. Lucarelli is a Professor in the ...
-
Evidence & EducationRadioiodine Treatment for Thyroid DiseaseRadioiodine is a radioactive isotope of ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.